Pegylated IFN alpha-2b/Ribavirin therapy for chronic hepatitis C with genotype Ib, high titer-analysis with viral clearance.
Not Applicable
- Conditions
- Chronic hepatitis C
- Registration Number
- JPRN-C000000175
- Lead Sponsor
- Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine
- Brief Summary
ot significant change
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Complicated with other liver diseases such as autoimmune hepatitis and alcoholic liver injury. (2)Liver cirrhosis, hepatic failure. (3)Drug allergy for IFN or ribavirin. (4)Drug allergy for vaccine. (5)Administration of other anti-viral or immunomodulatory treatment. (6)Pregnancy. (7)Depression. (8)Complicated with autoimmune disorders.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sustained virological response rate
- Secondary Outcome Measures
Name Time Method